The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.00
Bid: 38.00
Ask: 40.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.263%)
Open: 39.00
High: 39.00
Low: 39.00
Prev. Close: 39.00
ALT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

28 Oct 2022 07:00

RNS Number : 4316E
Altitude Group PLC
28 October 2022
 

Altitude Group plc

("Altitude", the "Company" or the "Group")

Grant of Options

Altitude Group plc (AIM: ALT), the operator of a leading marketplace for the global promotional products industry, announces that on 27 October 2022 it granted options over a total of 2,022,000 ordinary shares of 0.4p each ("Ordinary Shares") to certain directors of the Group (the "Options").

Nichole Stella, Chief Executive Officer, has been issued nil cost options over 1,062,000 Ordinary Shares. Following the issue of Options, Nichole will be interested in options over 2,062,000 Ordinary Shares in total.

Graham Feltham, Chief Financial Officer, has been issued nil cost options over 560,000 Ordinary Shares. Following the issue of Options, Graham will be interested in options over 1,004,444 Ordinary Shares in total.

Deborah Wilkinson, Chief Operating Officer, has been issued nil cost options over 400,000 Ordinary Shares. Following the issue of Options, Deborah will be interested in options over 1,210,000 Ordinary Shares in total.

The Options will vest over 3 years from the date of grant, subject to the following performance conditions, and expire 1 year after the third anniversary of the grant. Vesting of the Options is conditional on the achievement of stretching earnings per share and total shareholder return targets, and are only exercisable from the third anniversary of the date of grant.

In aggregate the Options, when added to other employee options already in existence, will result in employee options existing in relation to approximately 8.7 per cent. of the issued share capital of the Company. Of this, options over 8.1 per cent of the issued share capital of the Company are at exercise prices well in excess of the current share price of the Company, with exercise prices of between 46p and 105p.

For enquiries, please contact:

Altitude Group plc

Nichole Stella, Chief Executive Officer

Graham Feltham, Chief Financial Officer

 

Via Zeus Capital

Zeus (Nominated Adviser & Broker)

Dan Bate / David Foreman / James Edis (Investment Banking)

Dominic King (Corporate Broking)

Tel: 0203 829 5000

 

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

i) Nichole Stella

ii) Graham Feltham

iii) Deborah Wilkinson

2

Reason for the notification

a)

Position/Status:

 

i) Chief Executive Officer

ii) Chief Financial Officer

iii) Chief Operating Officer

b)

Initial Notification/Amendment:

 

Initial Notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

a)

Name:

Altitude Group plc

b)

LEI:

213800VACSTYYSI39R89

4.

Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument:

 

Identification code:

Ordinary shares of 0.4p

 

GB00B0LSFV82

b)

Nature of the transaction:

 

Grant of Options

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

i)

Nil

1,062,000

ii)

Nil

560,000

iii)

Nil

400,000

d)

Aggregated volume:

Price:

See above

e)

Date of the Transaction:

27th October 2022

f)

Place of the Transaction:

Off Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLVLBLLBLBFBE
Date   Source Headline
25th Mar 20209:43 amRNSDirector/PDMR Shareholding
23rd Mar 20204:41 pmRNSDirector/PDMR Shareholding
23rd Mar 20207:00 amRNSTrading Update and Board Change
18th Mar 20207:00 amRNSProposed disposal of AdProducts
17th Mar 202011:44 amRNSHolding(s) in Company
6th Jan 202011:00 amRNSPrice Monitoring Extension
6th Jan 20207:00 amRNSMajor Strategic Alliance in North America
12th Dec 20197:00 amRNSTrading update
8th Nov 20193:09 pmRNSPDMR Shareholding and Issue of Equity
7th Oct 20193:23 pmRNSDirector/PDMR Shareholding
7th Oct 20197:00 amRNSDirector/PDMR Shareholding
4th Oct 20191:49 pmRNSHolding(s) in Company
3rd Oct 20193:59 pmRNSDirector Shareholding and Exercise of Options
1st Oct 20192:42 pmRNSReplacement Director/PDMR Shareholding
30th Sep 20192:52 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim results
12th Sep 20198:57 amRNSHolding(s) in Company
5th Sep 201911:05 amRNSSecond Price Monitoring Extn
5th Sep 201911:00 amRNSPrice Monitoring Extension
5th Sep 20197:00 amRNSTrading Update and Notice of Interim Results
27th Aug 20197:03 amRNSChange of Accounting Reference Date
15th Aug 20199:15 amRNSPotential Disposal and Directorate Change
4th Jul 20195:15 pmRNSHolding(s) in Company
3rd Jul 20191:58 pmRNSDirector/PDMR Shareholding
1st Jul 201912:36 pmRNSResult of AGM
25th Jun 20197:00 amRNSGrant of Options
13th Jun 201912:16 pmRNSDirector/PDMR Shareholding
28th May 20197:00 amRNSUnaudited full year results and operational update
10th Apr 20197:00 amRNSYear-end trading update
15th Mar 20194:02 pmRNSDirector/PDMR Shareholding
11th Mar 20197:00 amRNSTwo appointments to subsidiary AIM Smarter LLC
26th Feb 20195:49 pmRNSHolding(s) in Company
21st Feb 201910:33 amRNSUpdate: Admission of Consideration Shares
1st Feb 20199:42 amRNSCorrection: Director / PDMR Shareholding
1st Feb 20197:00 amRNSDirector/PDMR Shareholding
31st Jan 201910:28 amRNSResult of GM and Completion of Placings
23rd Jan 20193:25 pmRNSHolding(s) in Company
22nd Jan 20197:00 amRNSHolding(s) in Company
16th Jan 20193:31 pmRNSUpdate: Admission of Consideration Shares
15th Jan 20197:00 amRNSClosing of Placings
11th Jan 20197:00 amRNSProposed Placing and Acquisition
19th Dec 20187:00 amRNSDebt Financing
6th Dec 20184:30 pmRNSHolding(s) in Company
5th Dec 20187:00 amRNSDirector Disclosures
29th Nov 20182:04 pmRNSInvestor Presentation
27th Nov 20187:00 amRNSDirectorate Change
27th Nov 20187:00 amRNSTrading Update
19th Nov 20189:07 amRNSHolding(s) in Company
12th Nov 20187:00 amRNSDirector/PDMR Shareholding
6th Nov 20183:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.